Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug 25;51(34):4566-4569.
doi: 10.1016/j.tetlet.2010.06.116.

Two step syntheses of fused quinoxaline-benzodiazepines and bis-benzodiazepines

Affiliations

Two step syntheses of fused quinoxaline-benzodiazepines and bis-benzodiazepines

Zhigang Xu et al. Tetrahedron Lett. .

Abstract

A two-step solution phase synthesis employing a double UDC (Ugi/Deprotect/Cyclize) strategy has been utilized to obtain fused 6,7,6,6-quinoxalinone-benzodiazepines and 6,7,7,6-bis-benzodiazepines. Optimization of the methodology to produce these tetracyclic scaffolds was enabled by microwave irradiation, incorporation of trifluoroethanol as solvent, and the use of the convertible isocyanide, 4-tert-butyl cyclohexen-1-yl isocyanide.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Targeted fused tetracyclic quinoxalinone-benzodiazepines 1, and bis-benzodiazepines 2.
Figure 2
Figure 2
Structures of bicyclic quinoxalinone-benzodiazepines (Ugi % yield, Cyclization % yield).
Figure 3
Figure 3
Structures of fused bis-benzodiazepines (Ugi % yield, Cyclization % yield).
Scheme 1
Scheme 1
Initial synthetic route to scaffold 1.
Scheme 2
Scheme 2
Proposed mechanism of synthesizing benzodiazepines.
Scheme 3
Scheme 3
New process of synthesizing compound 1.
Scheme 4
Scheme 4
Route to fused bis-benzodiazepine 2.

Similar articles

Cited by

References

    1. Bienayme H, Hulme C, Oddon G, Schmitt P. Chem Eur J. 2000;6(10):3321. - PubMed
    2. Larsen SD, Grieco PA. J Am Chem Soc. 1985;107:1768.
    3. Frantz DE, Morency L, Soheili A, Murry JE, Grabowski EJJ, Tillyer RD. Org Lett. 2004;6:843. - PubMed
    4. Dhawan R, Dghaym RD, Arndtsen BA. J Am Chem Soc. 2003;125:1474. - PubMed
    5. Rossen K, Pye PJ, Di Michele LM, Volante K, Reider PJ. Tetrahedron Lett. 1998;39:6823.
    1. Dolle RE, La Bourdonnec B, Goodman AJ, Morales GA, Thomas CJ, Zhang W. J Comb Chem. 2009;11:739–790. - PubMed
    2. Dõmling A. Chem Rev. 2006;106:17–89. - PubMed
    3. Hulme C, Gore V. Curr Med Chem. 2003;10:51–80. - PubMed
    4. Hulme C, Lee YS. Mol Div. 2008;12:1–15. - PubMed
    5. Hulme C, Nixey T. Curr Opin Drug Discovery Dev. 2003;6:921–929. - PubMed
    1. Ugi I. Angew Chem. 1962;74:9–22.
    2. Dõmling A, Ugi I. Angew Chem, Int Ed. 2000;39:3168–3210. - PubMed
    3. Hulme C, Peng J, Louridas B, Menard P, Krolikowski P, Kumar NV. Tetrahedron Lett. 1998;39:8047.
    4. Hulme C, Cherrier MP. Tetrahedron Lett. 1999;40:5295.
    5. Hulme C, Ma L, Labaudiniere R. Tetrahedron Lett. 2000;41:1509.
    6. Hulme C, Ma L, Romano J, Morton G, Tang SY, Cherrier MP, Choi S, Labaudiniere R. Tetrahedron Lett. 2000;41:1883.
    1. Nixey T, Tempest P, Hulme C. Tetrahedron Lett. 2002;43:1637.
    2. Hulme C, Ma L, Romano J, Cherrier MP, Salvino J, Labaudiniere R. Tetrahedron Lett. 2000;41:1889.
    3. Hulme C, Cherrier MP. Tetrahedron Lett. 1999;40:5295.
    4. Hulme C, Ma L, Labaudiniere R. Tetrahedron Lett. 2000;41:1509.
    5. Hulme C, Chappeta S, Griffith C, Lee YS, Dietrich J. Tetrahedron Lett. 2009;50:1939–1942.
    1. Hulme C, Peng J, Tang SY, Burns CJ, Morize I, Labaudiniere R. J Org Chem. 1998;63:8021–8023.
    2. Nixey T, Hulme C. Tetrahedron Lett. 2002;43:6833–6835.
    3. Habashita H, Kokubo M, Hamano SI, Hamanaka N, Toda M, Shibayama S, Tada H, Sagawa K, Fukushima D, Maeda K, Mitsuya H. J Med Chem. 2006;49:4140–4152. - PubMed
    4. Nishizawa R, Nishiyama T, Hisaichi K, Matsunaga N, Minamoto C, Habashita H, Takaoka Y, Toda M, Shibayama S, Tada H, Sagawa K, Fukushima D, Maeda K, Mitsuya H. Bioorg Med Chem Lett. 2007;17:727–731. - PubMed

LinkOut - more resources